243 related articles for article (PubMed ID: 12701977)
1. Radiochemotherapy for patients with locally advanced cervical cancer: early results.
Ozsaran Z; Yalman D; Yürüt V; Aras A; Ozsaran A; Hanhan M; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(2):191-4. PubMed ID: 12701977
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
3. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
King M; McConkey C; Latief TN; Hartley A; Fernando I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):38-45. PubMed ID: 16477918
[TBL] [Abstract][Full Text] [Related]
4. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
Small W; Winter K; Levenback C; Iyer R; Gaffney D; Asbell S; Erickson B; Jhingran A; Greven K
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1081-7. PubMed ID: 17398031
[TBL] [Abstract][Full Text] [Related]
5. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
6. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
9. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
10. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.
Souhami L; Seymour R; Roman TN; Stanimir GW; Trudeau M; Clark BG; Freeman CR
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):871-8. PubMed ID: 8244817
[TBL] [Abstract][Full Text] [Related]
11. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
13. Out-of-protocol concurrent use of cisplatin and radiation therapy in locally advanced cervical cancer: feasibility and survival.
Mancebo G; Gil-Moreno A; Vergés R; Martínez-Palones JM; Checa MA; Carreras JM; Giralt J; Xercavins J
Eur J Gynaecol Oncol; 2010; 31(1):18-22. PubMed ID: 20349775
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract][Full Text] [Related]
18. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
19. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]